Search

Catalogue Name :
SkinIR System
Cell Type/ Tissue:
TRANSKIN

In Stock

Tissue used as testing platform
TRANSKIN: Tissue engineered Human skin like tissue
Assay endpoints:
Keratinocyte viability test
Effect on NF-Kappa B Transcription factor in Keratinocytes
Keratinocyte proliferation test
Anti-inflammatory assay
Cell cycle assay
PDE 4 inhibition measurement
Involucrin/Loricin expression
Metabolite profiling
Keratinotoxicity test/
Keratinocyte associated senescence
Skin Penetration Test

Reference:

Avila AM, Bebenek I, Bonzo JA, Bourcier T, Davis Bruno KL, Carlson DB, Dubinion J, Elayan I, Harrouk W, Lee SL, Mendrick DL, Merrill JC, Peretz J, Place E, Saulnier M, Wange RL, Yao J, Zhao D, Brown PC. An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). Regul Toxicol Pharmacol. 2020 Jul;114:104662. doi: 10.1016/j.yrtph.2020.104662. Epub 2020 Apr 20. PMID: 32325112.

Available Resources

Catalogue Name :
SkinIR System
Cell Type/ Tissue:
TRANSKIN

Reviews

There are no reviews yet.

Write a review

Product has been added to your cart